Neuroendocrine tumors: Clinical practice guidelines in oncology Journal Article


Authors: Kulke, M. H.; Benson, A. B. 3rd; Bergsland, E.; Berlin, J. D.; Blaszkowsky, L. S.; Choti, M. A.; Clark, O. H.; Doherty, G. M.; Eason, J.; Emerson, L.; Engstrom, P. F.; Goldner, W. S.; Heslin, M. J.; Kandeel, F.; Kunz, P. L.; Kuvshinoff, B. W. 2nd; Moley, J. F.; Pillarisetty, V. G.; Saltz, L.; Schteingart, D. E.; Shah, M. H.; Shibata, S.; Strosberg, J. R.; Vauthey, J. N.; White, R.; Yao, J. C.
Article Title: Neuroendocrine tumors: Clinical practice guidelines in oncology
Abstract: Neuroendocrine tumors comprise a broad family of tumors, the most common of which are carcinoid and pancreatic neuroendocrine tumors. The NCCN Neuroendocrine Tumors Guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine tumors. Most of the recommendations pertain to well-differentiated, low- to intermediate-grade tumors. This updated version of the NCCN Guidelines includes a new section on pathology for diagnosis and reporting and revised recommendations for the surgical management of neuroendocrine tumors of the pancreas. © JNCCN - Journal of the National Comprehensive Cancer Network.
Keywords: immunohistochemistry; clinical feature; review; splenectomy; cancer localization; cancer recurrence; cisplatin; doxorubicin; sunitinib; artificial embolism; chemoembolization; hypertension; multimodality cancer therapy; cancer adjuvant therapy; cancer staging; nuclear magnetic resonance imaging; neoplasm staging; cancer grading; lymphadenectomy; pancreaticoduodenectomy; ki 67 antigen; cytoreductive surgery; paraganglioma; carboplatin; unindexed drug; metastasis; computer assisted tomography; classification; tumor volume; etoposide; lung non small cell cancer; tumor differentiation; cancer screening; calcitonin; clinical protocol; practice guideline; antineoplastic activity; adrenal cortex carcinoma; neuroendocrine tumor; cancer invasion; hypokalemia; colonoscopy; colon cancer; pancreas tumor; glucose blood level; stomach cancer; intestine resection; mitosis rate; carcinoid; clinical decision making; glucose; octreotide; diet therapy; cancer epidemiology; blood cell count; spironolactone; appendectomy; cancer classification; cytokeratin; cholecystectomy; pheochromocytoma; hemicolectomy; rectum cancer; everolimus; catecholamine; dopamine; functional status; thymus cancer; mitotane; hospital management; endoscopic echography; adrenal tumor; metadrenalin; somatostatin; neuroendocrine tumors; hormone synthesis; pentetreotide; streptozocin; insulinoma; synaptophysin; hormone blood level; appendix cancer; 5 hydroxyindoleacetic acid; chromogranin a; duodenum cancer; esophagogastroduodenoscopy; gastrinoma; glucagonoma; cushing syndrome; corticosteroid therapy; multiple endocrine neoplasia; glucagon; hormone urine level; parathyroid hormone related protein; eplerenone; diazoxide; c peptide; aldosterone; pancreas polypeptide; dopamine blood level; hyperaldosteronism; jejunum cancer
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 10
Issue: 6
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2012-06-01
Start Page: 724
End Page: 764
Language: English
PROVIDER: scopus
PUBMED: 22679117
DOI: 10.6004/jnccn.2012.0075
DOI/URL:
Notes: - "Export Date: 1 August 2012" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz
Related MSK Work